GenScript Biotech Corporation is a global biotechnology group established in 2002, with a strong presence across North America, Europe, Greater China, and Asia Pacific. The company operates in four major areas: life science contract research organization (CRO) services, enzyme and synthetic biology products, biologics development and manufacturing, and cell therapy. GenScript aims to enhance the health of humans and nature through its advanced gene synthesis technology and commitment to reliability in biotech solutions. ProBio, a subsidiary, provides comprehensive contract development and manufacturing services focusing on cell and gene therapy, vaccines, and biologics, facilitating accelerated drug development for its clients. With a mission centered on innovation and quality, GenScript prioritizes excellence and efficiency in serving the global biotech community.